Exploring PI3K Pathway Inhibitors for Acute Myeloid Leukemia: A Drug-Repurposing Approach
- DOI
- 10.26650/experimed.1358971
- Published
- 2023-12-28
- Container
- Experimed
- Publisher
- Istanbul University
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.26650/experimed.1358971,
title = {Exploring PI3K Pathway Inhibitors for Acute Myeloid Leukemia: A Drug-Repurposing Approach},
author = {Cansu Ergun and Buse Kiremitçi and Gizem Arslantaş and Busenur Bozkurt and Gizem Ayna Duran and Yağmur Kiraz},
year = {2023},
journal = {Experimed},
doi = {10.26650/experimed.1358971},
url = {https://doi.org/10.26650/experimed.1358971}
}RIS
TY - JOUR TI - Exploring PI3K Pathway Inhibitors for Acute Myeloid Leukemia: A Drug-Repurposing Approach AU - Cansu Ergun AU - Buse Kiremitçi AU - Gizem Arslantaş AU - Busenur Bozkurt AU - Gizem Ayna Duran AU - Yağmur Kiraz PY - 2023 JO - Experimed DO - 10.26650/experimed.1358971 UR - https://doi.org/10.26650/experimed.1358971 ER -
APA
Ergun, C., Kiremitçi, B., Arslantaş, G., Bozkurt, B., Duran, G. A., & Kiraz, Y. (2023). Exploring PI3K Pathway Inhibitors for Acute Myeloid Leukemia: A Drug-Repurposing Approach. Experimed. https://doi.org/10.26650/experimed.1358971
Source records
- crossref · retrieved 2026-11-06T17:44:32.081Z